Timber Pharmaceuticals CEO David Tierney receives $1.1M in 2019
Timber Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: May 22, 2019
Timber Pharmaceuticals reported fiscal year 2019 executive compensation information on May 22, 2019.
In 2019, seven executives at Timber Pharmaceuticals received on average a compensation package of $403K, a 49% decrease compared to previous year.
Average pay of disclosed executives at Timber Pharmaceuticals
David S. Tierney, Chief Executive Officer, received $1.1M in total. 85% of Tierney's compensation, or $958K, was in option awards. Tierney also received $169K in salary.
Anja Krammer, Former President and Director, received a compensation package of $590K, which decreased by 52% compared to previous year. 42% of the compensation package, or $249K, was in salary.
John Koconis, Chief Executive Officer, earned $280K in 2019.
Kin F. Chan, Executive Vice President of Research and Technology, received $270K in 2019, which decreases by 58% compared to 2018.
Zachary Rome, Chief Operating Officer, earned $195K in 2019.
Steven Bosacki, Chief Executive Officer, received $185K in 2019.
Greg Kitchener, Chief Financial Officer, earned $174K in 2019, a 66% decrease compared to previous year.
Related executives
David Tierney
Timber Pharmaceuticals
Chief Executive Officer
Anja Krammer
Timber Pharmaceuticals
Former President and Director
Kin Chan
Timber Pharmaceuticals
Executive Vice President of Research and Technology
Greg Kitchener
Timber Pharmaceuticals
Chief Financial Officer
John Koconis
Timber Pharmaceuticals
Chief Executive Officer
Zachary Rome
Timber Pharmaceuticals
Chief Operating Officer
Steven Bosacki
Timber Pharmaceuticals
Chief Executive Officer
You may also like
Source: SEC filing on May 22, 2019.